182 related articles for article (PubMed ID: 2476850)
1. Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor.
MacKinnon R; Miller C
Science; 1989 Sep; 245(4924):1382-5. PubMed ID: 2476850
[TBL] [Abstract][Full Text] [Related]
2. Mapping the receptor site for charybdotoxin, a pore-blocking potassium channel inhibitor.
MacKinnon R; Heginbotham L; Abramson T
Neuron; 1990 Dec; 5(6):767-71. PubMed ID: 1702643
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
Jäger H; Grissmer S
Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
[TBL] [Abstract][Full Text] [Related]
4. The charybdotoxin receptor of a Shaker K+ channel: peptide and channel residues mediating molecular recognition.
Goldstein SA; Pheasant DJ; Miller C
Neuron; 1994 Jun; 12(6):1377-88. PubMed ID: 7516689
[TBL] [Abstract][Full Text] [Related]
5. Interaction of charybdotoxin with permeant ions inside the pore of a K+ channel.
Park CS; Miller C
Neuron; 1992 Aug; 9(2):307-13. PubMed ID: 1379820
[TBL] [Abstract][Full Text] [Related]
6. A strongly interacting pair of residues on the contact surface of charybdotoxin and a Shaker K+ channel.
Naranjo D; Miller C
Neuron; 1996 Jan; 16(1):123-30. PubMed ID: 8562075
[TBL] [Abstract][Full Text] [Related]
7. A marine snail neurotoxin shares with scorpion toxins a convergent mechanism of blockade on the pore of voltage-gated K channels.
García E; Scanlon M; Naranjo D
J Gen Physiol; 1999 Jul; 114(1):141-57. PubMed ID: 10398697
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of charybdotoxin to high-conductance calcium-activated potassium channels: identification of the covalently modified toxin residue.
Munujos P; Knaus HG; Kaczorowski GJ; Garcia ML
Biochemistry; 1995 Aug; 34(34):10771-6. PubMed ID: 7545007
[TBL] [Abstract][Full Text] [Related]
9. A point mutation in a Shaker K+ channel changes its charybdotoxin binding site from low to high affinity.
Goldstein SA; Miller C
Biophys J; 1992 Apr; 62(1):5-7. PubMed ID: 1376173
[No Abstract] [Full Text] [Related]
10. Mapping function to structure in a channel-blocking peptide: electrostatic mutants of charybdotoxin.
Park CS; Miller C
Biochemistry; 1992 Sep; 31(34):7749-55. PubMed ID: 1380827
[TBL] [Abstract][Full Text] [Related]
11. Charybdotoxin block of Shaker K+ channels suggests that different types of K+ channels share common structural features.
MacKinnon R; Reinhart PH; White MM
Neuron; 1988 Dec; 1(10):997-1001. PubMed ID: 2483094
[TBL] [Abstract][Full Text] [Related]
12. Electrostatic distance geometry in a K+ channel vestibule.
Stocker M; Miller C
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9509-13. PubMed ID: 7524078
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of charybdotoxin block of a voltage-gated K+ channel.
Goldstein SA; Miller C
Biophys J; 1993 Oct; 65(4):1613-9. PubMed ID: 7506068
[TBL] [Abstract][Full Text] [Related]
14. Interaction of agitoxin2, charybdotoxin, and iberiotoxin with potassium channels: selectivity between voltage-gated and Maxi-K channels.
Gao YD; Garcia ML
Proteins; 2003 Aug; 52(2):146-54. PubMed ID: 12833539
[TBL] [Abstract][Full Text] [Related]
15. Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels.
Giangiacomo KM; Sugg EE; Garcia-Calvo M; Leonard RJ; McManus OB; Kaczorowski GJ; Garcia ML
Biochemistry; 1993 Mar; 32(9):2363-70. PubMed ID: 7680230
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic interaction between charybdotoxin and a tetrameric mutant of Shaker K(+) channels.
Thompson J; Begenisich T
Biophys J; 2000 May; 78(5):2382-91. PubMed ID: 10777734
[TBL] [Abstract][Full Text] [Related]
17. Block of maurotoxin and charybdotoxin on human intermediate-conductance calcium-activated potassium channels (hIKCa1).
Visan V; Sabatier JM; Grissmer S
Toxicon; 2004 Jun; 43(8):973-80. PubMed ID: 15208030
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-controlled binding of a peptide neurotoxin to its K+ channel receptor.
Miller C
Biochemistry; 1990 Jun; 29(22):5320-5. PubMed ID: 1696498
[TBL] [Abstract][Full Text] [Related]
19. Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor.
Hidalgo P; MacKinnon R
Science; 1995 Apr; 268(5208):307-10. PubMed ID: 7716527
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic localization of [125I]charybdotoxin binding sites in rat brain.
Gehlert DR; Gackenheimer SL; Robertson DW
Neurosci Lett; 1992 Jun; 140(1):25-9. PubMed ID: 1383889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
